4 results
The objective of this study is to evaluate the effect of the 4 successive monthly subcutaneous administrations of 30 mg of gevokizumab (in part A) , as well as 60mg (in part B) of the protocol, versus placebo on the reduction of arterial wall…
The primary objective of this first-in-man safety and feasibility study is to assess the safety of the Volcano PreView FL.IVUS catheter when used after successful coronary stenting.
The objective of this study is to explore the efficacy and safety of gevokizumab in patients with Schnitzler syndrome.
The primary objective is to investigate the validity of the volumes measured by the Hexoskin shirt relative to a (mobile) spirometer in healthy subjects and in COPD patients. Secondary objective are to determine reliability of the Hexoskin shirt…